- Home
- KLXE vs GRCE Comparison
KLXE vs GRCE Comparison
Compare KLXE & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- GRCE
- Stock Information
- Founded
- KLXE 2018
- GRCE 2002
- Country
- KLXE United States
- GRCE United States
- Employees
- KLXE N/A
- GRCE N/A
- Industry
- KLXE Oilfield Services/Equipment
- GRCE
- Sector
- KLXE Energy
- GRCE
- Exchange
- KLXE Nasdaq
- GRCE NYSE
- Market Cap
- KLXE 29.1M
- GRCE 32.1M
- IPO Year
- KLXE N/A
- GRCE N/A
- Fundamental
- Price
- KLXE $1.78
- GRCE $2.30
- Analyst Decision
- KLXE Hold
- GRCE Strong Buy
- Analyst Count
- KLXE 1
- GRCE 1
- Target Price
- KLXE $4.50
- GRCE $12.00
- AVG Volume (30 Days)
- KLXE 282.6K
- GRCE 23.2K
- Earning Date
- KLXE 05-08-2025
- GRCE 05-15-2025
- Dividend Yield
- KLXE N/A
- GRCE N/A
- EPS Growth
- KLXE N/A
- GRCE N/A
- EPS
- KLXE N/A
- GRCE N/A
- Revenue
- KLXE $709,300,000.00
- GRCE N/A
- Revenue This Year
- KLXE $2.03
- GRCE N/A
- Revenue Next Year
- KLXE $4.88
- GRCE N/A
- P/E Ratio
- KLXE N/A
- GRCE N/A
- Revenue Growth
- KLXE N/A
- GRCE N/A
- 52 Week Low
- KLXE $1.51
- GRCE $1.75
- 52 Week High
- KLXE $7.66
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- KLXE 31.63
- GRCE N/A
- Support Level
- KLXE $1.64
- GRCE N/A
- Resistance Level
- KLXE $1.93
- GRCE N/A
- Average True Range (ATR)
- KLXE 0.29
- GRCE 0.00
- MACD
- KLXE 0.02
- GRCE 0.00
- Stochastic Oscillator
- KLXE 15.79
- GRCE 0.00
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.